Menu
Kedrion was one of two drugmakers to issue recent notices to covered entities on a federal government agency website.

Kedrion Posts 340B Refund Notice; Mylan Issue NDC Changes

Bella Czajkowski, National Correspondent Views
Drugmaker Kedrion Biopharma has posted a refund notice to 340B providers, and Mylan notified covered entities of National Drug Code [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.